Hospital
Schoolcraft Memorial Hospital
Schoolcraft Memorial Hospital was paid $4.20M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoSCHOOLCRAFT MEMORIAL HOSPITAL
MANISTIQUE, MI 49854
MANISTIQUE, MI 49854
33aNPI1700805157assigned 07/18/2006
33bProvider typeCritical Access Hospital
28Total paid$4.20M
24GClaims133,032
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#19 of 31
Median peer was paid$6.03M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,823 | $380K | |
| 2019 | 18,068 | $380K | |
| 2020 | 14,550 | $437K | |
| 2021 | 18,921 | $667K | |
| 2022 | 21,415 | $786K | |
| 2023 | 24,562 | $848K | |
| 2024incomplete | 17,693 | $701K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 7,216 | 5,870 | $757K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 2,835 | 2,513 | $629K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 14% | 7,895 | 6,670 | $579K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.8% | 954 | 881 | $369K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.4% | 5,692 | 4,439 | $352K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 3.8% | 2,056 | 960 | $160K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.0% | 3,302 | 3,042 | $126K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 910 | 810 | $116K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 3,694 | 1,175 | $112K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 763 | 554 | $95K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.9% | 2,429 | 2,117 | $82K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 976 | 718 | $69K |
96 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 1,363 | $62K |
| 80061 | Lipid panel | <1% | 3,339 | $38K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 911 | $38K |
| 80053 | Comprehensive metabolic panel | <1% | 10,200 | $36K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 757 | $33K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,180 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,166 | $32K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 123 | $29K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 471 | $29K |
| 71045 | Radiologic examination, chest; single view | <1% | 564 | $29K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,696 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,492 | $27K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 702 | $26K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,022 | $22K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,176 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,128 | $21K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 934 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,867 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 302 | $16K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 706 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 459 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,338 | $14K |
| 73630 | <1% | 975 | $13K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 110 | $12K |
| 97161 | <1% | 149 | $10K | |
| 87634 | <1% | 292 | $10K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 211 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 130 | $9K |
| 81001 | <1% | 6,150 | $7K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 190 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 59 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,587 | $5K |
| 84439 | <1% | 1,051 | $5K | |
| 80306 | <1% | 899 | $5K | |
| Q3014 | Telehealth originating site facility fee | <1% | 304 | $4K |
| 83735 | <1% | 2,403 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 205 | $3K |
| 82607 | <1% | 421 | $3K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 40 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 644 | $3K |
| 81025 | <1% | 1,030 | $3K | |
| 20610 | <1% | 23 | $3K | |
| 87186 | <1% | 759 | $3K | |
| 82746 | <1% | 339 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 96 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 823 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 252 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 139 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 139 | $2K |
| 86140 | <1% | 2,202 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 33 | $2K |
| 87070 | <1% | 372 | $2K | |
| 85610 | <1% | 1,563 | $1K | |
| 87077 | <1% | 305 | $1K | |
| 87581 | <1% | 110 | $995.09 | |
| 87486 | <1% | 110 | $995.09 | |
| 71271 | <1% | 12 | $967.08 | |
| 82728 | <1% | 143 | $933.50 | |
| 83690 | <1% | 1,168 | $920.87 | |
| 84145 | <1% | 693 | $615.39 | |
| 82150 | <1% | 870 | $544.58 | |
| 84703 | <1% | 472 | $487.73 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 28 | $445.34 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 309 | $388.59 |
| 82550 | <1% | 853 | $386.77 | |
| 86803 | <1% | 38 | $313.33 | |
| 83605 | <1% | 783 | $223.66 | |
| 84484 | <1% | 888 | $160.14 | |
| A9270 | Non-covered item or service | <1% | 317 | $144.00 |
| 85651 | <1% | 109 | $135.57 | |
| 85027 | <1% | 41 | $119.36 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 15 | $109.70 |
| 86900 | <1% | 14 | $91.09 | |
| 85730 | <1% | 221 | $75.06 | |
| 85652 | <1% | 65 | $73.47 | |
| 87088 | <1% | 25 | $64.96 | |
| 83540 | <1% | 12 | $42.93 | |
| 85379 | <1% | 51 | $7.68 | |
| 87040 | <1% | 128 | $6.48 | |
| 94761 | 0% | 132 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 576 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 122 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 37 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 210 | $0.00 |
| 82962 | 0% | 12 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 108 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 271 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 291 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 15 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 42 | $0.00 |
| 86901 | 0% | 14 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 424 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 481 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 921 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 359 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERTAPELLE, ANDY (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Schoolcraft Memorial Hospital | Manistique, MI | $2.84M |
| Schoolcraft Memorial Hospital | Naubinway, MI | $38K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.